What should we be focusing on in CLL research?
Panel discussion on novel therapies and targets for lymphoma
John Gribben et al.
Virus-specific T cells - effectiveness, safety profile and use
Pros and cons of CML first-line therapy
Importance of taking into consideration new and traditional treatment options for CLL patients